Treatment with thalidomide leads to a striking reduction in symptoms and a subsequent improvement of quality of life in patients with severe arteriovenous malformations. That is the conclusion of a study in 18 patients, performed by Prof. Laurence Boon and Prof. Miikka Vikkula, in a long-standing collaboration between de Duve Institute and the Centre for Vascular Anomalies at University Hospital Saint-Luc.
Arteriovenous malformations (AVMs) are difficult-to-treat vascular anomalies in which abnormal connections are formed between high-pressure blood vessels (arteries) and low-pressure blood vessels (veins). Lesions can arise anywhere in the body. They are painful and may cause recurrent and sometimes life-threatening bleeding, ulceration and functional disability. Though mostly present at birth, AVMs usually become visible and symptomatic in adolescence or adulthood, and often evolve over time with increasingly severe symptoms. Common treatment is embolization (deliberate blocking of blood vessels) followed by surgical resection. However, complete resection is rarely possible and partial resection often leads to dramatic worsening.
Some people with AVMs can live relatively normal lives, but even in less severe cases there is always the risk that the abnormal tangles of blood vessels can burst and may cause a stroke when in the brain. About one in every hundred AVM patients suffers a stroke each year.
“Our group has been studying the causes of vascular abnormalities for 30 years”, says Prof. Vikkula, head of the laboratory of Human Genetics at de Duve Institute. “We have identified several genetic causes and have been able to show that certain mutations activate the signalling inside the cells of blood vessel walls, and this promotes the abnormal formation of blood vessels (angiogenesis). This led us to wonder about the possibility of using thalidomide to inhibit abnormal blood vessel formation”. Thalidomide was used as a sedative drug for pregnant women in the 1950s and it became infamous for its teratogenic properties. These effects were later shown to be due to strong inhibitory effects on angiogenesis of thalidomide.
After showing that a vascular malformation could be corrected in a mouse model, Prof. Laurence Boon from the Centre for Vascular Anomalies at University Hospital Saint-Luc, started in 2010 a clinical study into the use of thalidomide in AVMs. She recruited 18 patients, aged between 19 and 70, with severe malformations that could not be treated by conventional approaches.
“All the patients experienced a rapid reduction of pain, together with cessation of bleeding and the healing of ulcers where these were present”, says Prof. Vikkula. “Three patients with cardiac failure also saw these problems resolved, and one AVM appeared to be completely cured after 19 months of thalidomide and an eight-year follow-up”. The researchers showed in five patients that combined treatment with embolization permitted thalidomide dose reduction with clinical improvement. Reducing the dose led to less side-effects during the treatment.
Further clinical studies are needed to confirm the safety and efficacy of thalidomide treatment in AVMs. “Although our study is relatively small, the results are convincing, and we hope that they will be confirmed by larger trials”, says Prof. Vikkula. These results give great hope for a better future for patients affected by an AVM.
(Picture from the article in Nature Cardiovascular Research, see below)
Article describing the research
Case report study of thalidomide therapy in 18 patients with severe arteriovenous malformation.
Boon LM, Dekeuleneer V, Coulie J, Marot L, Bataille A-C, Hammer F, Clapuyt P, Jeanjean A, Dompmartin A & Vikkula M.
Nature Cardiovascular Research. Jun 10, 2022. doi: 10.1038/s44161-022-00080-2
In the press
EurekAlert.org - Thalidomide is an effective treatment for abnormal blood vessel formations - 10/06/2022
News-Medical.net - Study reveals the benefits of using thalidomide in patients with severe arteriovenous malformations - 10/06/2022
Revyuh.com - A New Option To Prevent Stroke In Patients With AVMs - 10/06/2022
InsideHeadline.com - Thalidomide IS Safe… But Only For Treating Rare Blood Vessel Condition- 10/06/2022
FloridaNewsTimes.com - Thalidomide is an effective treatment for abnormal angioplasty - 10/06/2022
WSTPost.com - Thalidomide IS safe… but only for treating rare blood vessel disorders - 11/06/2022
StudyFinds.org - Old morning sickness drug that caused birth defects repurposed to prevent strokes - 11/06/2022
News.knowledia.com - Infamous drug that causes birth defects could prevent bleeding and strokes - 11/06/2022
CosmosMagazine.com - Thalidomide could be used as a therapeutic - 12/06/2022
WorldFace.uk - Thalidomide could be used as a therapeutic for AVMs - 12/06/2022
Talker.news - Notorious drug could help prevent hemorrhages and strokes - 13/06/2022
HealthyNewsUSA.net - Thalidomide effectively treats blood vessel-damaging disorders in humans - 13/06/2022
GenEngNews.com - Thalidomide Effectively Treats Damaging Blood Vessel Disorder in Humans - 13/06/2022
List123.com - Thalidomide works by treating human blood vessel abnormalities effectively - 13/06/2022
NewsBoardForMe.com - Thalidomide is an effective remedy for the treatment of abnormal blood vessel formations - 14/06/2022
SciTechDaily.com - Cheaper and Safer: A New Effective Treatment for Abnormal Blood Vessel Formations - 28/08/2022
NewsTimes.com.ng - A New Effective Treatment for Abnormal Blood Vessel Formations - 28/08/2022
Also on MedicalXpress.com, MailOnSunday.co.uk, ScienMag.com, TheSunBest.com, Singapore-Times.com, MirageNews.com, PublicNewsTime.com, NewsBreak.com, USMail24.com, WebTimes.uk, TrendRadars.com, Zipe-education.com, GranthshalaNews.com, Funancial.news, Behous.co.uk, NewsFinale.com, WhatsNew2day.com, NaijaOnPoint.com.ng, UKPrimeNews.com, ExpressDigest.com, DailyUKnews.com, MedicalDialogues.in, Mtech-imaging-usa.com, Jishu.medpeer.cn, ReachMD.com & ScientificInquirer.com
LeSpecialiste.be - L'UCLouvain fait une découverte importante pour les malformations artério-veineuses - 10/06/2022
Fr.postus.com - La thalidomide est un traitement efficace pour les formations anormales de vaisseaux sanguins - 10/06/2022
Fr.postus.com - La thalidomide traite efficacement les troubles endommageant les vaisseaux sanguins chez l’homme - 13/06/2022
DailyScience.be - La thalidomide pour lutter contre les malformations artério-veineuses - 16/06/2022
Fr.postus.com - Un nouveau traitement efficace pour les formations anormales de vaisseaux sanguins - 28/08/2022
BarlettaWeb.com - Talidomide è un trattamento efficace per le formazioni anormali dei vasi sanguigni - 10/06/2022
Es.postus.com - Medicamento infame que causa defectos de nacimiento podría prevenir hemorragias y accidentes cerebrovasculares - 10/06/2022
InfoSalus.com - Revelan beneficios de la talidomida en pacientes con malformaciones arteriovenosas graves - 28/06/2022
AllNewsPress.com - Thalidomid IST sicher … aber nur zur Behandlung seltener Blutgefäßerkrankungen - 11/06/2022
CorreioBraziliense.com.br - Perigoso para grávidas, Talidomida atenua a má formação de vasos sanguíneos - 11/06/2022
RynekZdrowia.pl - Talidomid może pomóc osobom z nieprawidłowym rozwojem naczyń krwionośnych - 19/06/2022
TerMedia.pl - Talidomid w terapii pacjentów z niewydolnością serca - 20/06/2022
PulsMedycyny.pl - Kolejne wskazanie dla talidomidu? Może pomóc w leczeniu malformacji naczyniowych - 20/06/2022
Niezalezna.pl - Kontrowersyjny lek pomoże w leczeniu naczyń krwionośnych? - 28/06/2022
ItaliaSalute.It - Malformazioni arterovenose, talidomide utile - 15/07/2022
nipponese.news - 異常な血管形成に対する新しい効果的な治療法 - 28/08/2022
cnBeta.com - 研究发现沙利度胺可用于治疗异常的血管形成 - 29/08/2022